GoodRx Holdings, Inc. (NASDAQ:GDRX) Q1 2023 Earnings Conference Call May 10, 2023 8:00 AM ET Company Participants Aubrey Reynolds - Senior Manager Investor Relations Doug Hirsch - Chief Mission Officer Trevor Bezdek - Chairman Karsten Voermann - Chief Financial Officer Scott Wagner - Interim Chief Executive Officer Conference Call Participants Stephanie Davis - SVB Leerink Sandy Draper - Guggenheim Charles Rhyee - Cowen Jian Li - Evercore ISI Michael Cherny - Bank of America Stan Berenshteyn - Wells Fargo ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______. Commission File Number: 001-39549 GoodRx Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 47-5104396 (State or o ...

GoodRx Holdings, Inc. (NASDAQ:GDRX) Q4 2022 Earnings Conference Call February 28, 2023 5:00 PM ET Company Representatives Doug Hirsch - Co-Founders, Co-Chief Executive Officer Trevor Bezdek - Co-Founders, Co-Chief Executive Officer Karsten Voermann - Chief Financial Officer Aubrey Reynolds - Senior Investor Relations Manager Conference Call Participants Mark Mahaney - Evercore ISI Mitchell Kellett - Guggenheim Lucas Romanski - Cowen Michael Cherny - Bank of America Craig Hettenbach - Morgan Stanley Eric She ...

| --- | --- | --- | --- | |-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-39549 GoodRx Holdings, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 47-5104396 (State or other jurisdiction ...

GoodRx Holdings, Inc. (NASDAQ:GDRX) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Whitney Notaro – Vice President-Investor Relations Doug Hirsch – Co-Founder and Co-Chief Executive Officer Trevor Bezdek – Co-Founder and Co-Chief Executive Officer Karsten Voermann – Chief Financial Officer Conference Call Participants Jailendra Singh – Truist Michael Cherny – Bank of America Eric Sheridan – Goldman Sachs Doug Anmuth – JPMorgan Stephanie Davis – SVB Securities Craig Hettenb ...

Q3 2022 Earnings Presentation November 8, 2022 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our future operations, growth and financial results, the benefits to consumers or GoodRx of our agreements with pa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 GoodRx Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39549 Delaware 47-5104396 (State or other jurisd ...

GoodRx Holdings, Inc. (NASDAQ:GDRX) Q2 2022 Earnings Conference Call August 8, 2022 5:00 PM ET Company Participants Whitney Notaro - Vice President-Investor Relations Doug Hirsch - Co-Founders & Co-Chief Executive Officer Trevor Bezdek - Co-Founders & Co-Chief Executive Officer Karsten Voermann - Chief Financial Officer Conference Call Participants Glen Santangelo - Jefferies Sandy Draper - Guggenheim Partners Stephanie Davis - SVB Securities Michael Cherny - BofA Craig Hettenbach - Morgan Stanley Mark Maha ...

FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 (855) 268-2822 (Registrant's telephone number, including area code) N/A (Former name, former address and former fiscal year, if changed since last report) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Com ...